Reference
Aguirre C, et al. Long-term Efficacy and Safety in a Series of Multiple Sclerosis Patients Treated with Alemtuzumab in Clinical Practice. Multiple Sclerosis Journal 29 (Suppl.): 200, No. 2, May 2023. Available from: URL: http://doi.org/10.1177/13524585231169437 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1967, 26 (2023). https://doi.org/10.1007/s40278-023-43833-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-43833-7